179 related articles for article (PubMed ID: 23383274)
1. Exome sequencing of germline DNA from non-BRCA1/2 familial breast cancer cases selected on the basis of aCGH tumor profiling.
Hilbers FS; Meijers CM; Laros JF; van Galen M; Hoogerbrugge N; Vasen HF; Nederlof PM; Wijnen JT; van Asperen CJ; Devilee P
PLoS One; 2013; 8(1):e55734. PubMed ID: 23383274
[TBL] [Abstract][Full Text] [Related]
2. A non-BRCA1/2 hereditary breast cancer sub-group defined by aCGH profiling of genetically related patients.
Didraga MA; van Beers EH; Joosse SA; Brandwijk KI; Oldenburg RA; Wessels LF; Hogervorst FB; Ligtenberg MJ; Hoogerbrugge N; Verhoef S; Devilee P; Nederlof PM
Breast Cancer Res Treat; 2011 Nov; 130(2):425-36. PubMed ID: 21286804
[TBL] [Abstract][Full Text] [Related]
3. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
[TBL] [Abstract][Full Text] [Related]
4. Combined tumor genomic profiling and exome sequencing in a breast cancer family implicates ATM in tumorigenesis: A proof of principle study.
Bubien V; Bonnet F; Dupiot-Chiron J; Barouk-Simonet E; Jones N; de Reynies A; MacGrogan G; Sevenet N; Letouzé E; Longy M
Genes Chromosomes Cancer; 2017 Nov; 56(11):788-799. PubMed ID: 28691344
[TBL] [Abstract][Full Text] [Related]
5. Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus.
Kainu T; Juo SH; Desper R; Schaffer AA; Gillanders E; Rozenblum E; Freas-Lutz D; Weaver D; Stephan D; Bailey-Wilson J; Kallioniemi OP; Tirkkonen M; Syrjäkoski K; Kuukasjärvi T; Koivisto P; Karhu R; Holli K; Arason A; Johannesdottir G; Bergthorsson JT; Johannsdottir H; Egilsson V; Barkardottir RB; Johannsson O; Haraldsson K; Sandberg T; Holmberg E; Grönberg H; Olsson H; Borg A; Vehmanen P; Eerola H; Heikkila P; Pyrhönen S; Nevanlinna H
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9603-8. PubMed ID: 10944226
[TBL] [Abstract][Full Text] [Related]
6. Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families.
Shahi RB; De Brakeleer S; Caljon B; Pauwels I; Bonduelle M; Joris S; Fontaine C; Vanhoeij M; Van Dooren S; Teugels E; De Grève J
BMC Cancer; 2019 Apr; 19(1):313. PubMed ID: 30947698
[TBL] [Abstract][Full Text] [Related]
7. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide linkage scan reveals three putative breast-cancer-susceptibility loci.
Rosa-Rosa JM; Pita G; Urioste M; Llort G; Brunet J; Lázaro C; Blanco I; Ramón y Cajal T; Díez O; de la Hoya M; Caldés T; Tejada MI; González-Neira A; Benítez J
Am J Hum Genet; 2009 Feb; 84(2):115-22. PubMed ID: 19147119
[TBL] [Abstract][Full Text] [Related]
9. BRCA1 and BRCA2 germline mutations in Moroccan breast/ovarian cancer families: novel mutations and unclassified variants.
Tazzite A; Jouhadi H; Nadifi S; Aretini P; Falaschi E; Collavoli A; Benider A; Caligo MA
Gynecol Oncol; 2012 Jun; 125(3):687-92. PubMed ID: 22425665
[TBL] [Abstract][Full Text] [Related]
10. Family-specific, novel, deleterious germline variants provide a rich resource to identify genetic predispositions for BRCAx familial breast cancer.
Wen H; Kim YC; Snyder C; Xiao F; Fleissner EA; Becirovic D; Luo J; Downs B; Sherman S; Cowan KH; Lynch HT; Wang SM
BMC Cancer; 2014 Jun; 14():470. PubMed ID: 24969172
[TBL] [Abstract][Full Text] [Related]
11. Mutation analysis of BRCA1 and BRCA2 genes in Iranian high risk breast cancer families.
Pietschmann A; Mehdipour P; Mehdipour P; Atri M; Hofmann W; Hosseini-Asl SS; Scherneck S; Mundlos S; Peters H
J Cancer Res Clin Oncol; 2005 Aug; 131(8):552-8. PubMed ID: 15918047
[TBL] [Abstract][Full Text] [Related]
12. BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models.
Capalbo C; Ricevuto E; Vestri A; Ristori E; Sidoni T; Buffone O; Adamo B; Cortesi E; Marchetti P; Scambia G; Tomao S; Rinaldi C; Zani M; Ferraro S; Frati L; Screpanti I; Gulino A; Giannini G
Ann Oncol; 2006 Jun; 17 Suppl 7():vii34-40. PubMed ID: 16760289
[TBL] [Abstract][Full Text] [Related]
13. Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic.
Martin AM; Blackwood MA; Antin-Ozerkis D; Shih HA; Calzone K; Colligon TA; Seal S; Collins N; Stratton MR; Weber BL; Nathanson KL
J Clin Oncol; 2001 Apr; 19(8):2247-53. PubMed ID: 11304778
[TBL] [Abstract][Full Text] [Related]
14. Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes.
Stefansson OA; Jonasson JG; Johannsson OT; Olafsdottir K; Steinarsdottir M; Valgeirsdottir S; Eyfjord JE
Breast Cancer Res; 2009; 11(4):R47. PubMed ID: 19589159
[TBL] [Abstract][Full Text] [Related]
15. Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene.
Ticha I; Kleibl Z; Stribrna J; Kotlas J; Zimovjanova M; Mateju M; Zikan M; Pohlreich P
Breast Cancer Res Treat; 2010 Nov; 124(2):337-47. PubMed ID: 20135348
[TBL] [Abstract][Full Text] [Related]
16. Considerations for comprehensive assessment of genetic predisposition in familial breast cancer.
Lynch H; Synder C; Wang SM
Breast J; 2015; 21(1):67-75. PubMed ID: 25472498
[TBL] [Abstract][Full Text] [Related]
17. Targeted sequencing to discover germline variants in the BRCA1 and BRCA2 genes in a Russian population and their association with breast cancer risk.
Solodskikh SA; Panevina AV; Gryaznova MV; Gureev AP; Serzhantova OV; Mikhailov AA; Maslov AY; Popov VN
Mutat Res; 2019 Jan; 813():51-57. PubMed ID: 30611917
[TBL] [Abstract][Full Text] [Related]
18. Almost 2% of Spanish breast cancer families are associated to germline pathogenic mutations in the ATM gene.
Tavera-Tapia A; Pérez-Cabornero L; Macías JA; Ceballos MI; Roncador G; de la Hoya M; Barroso A; Felipe-Ponce V; Serrano-Blanch R; Hinojo C; Miramar-Gallart MD; Urioste M; Caldés T; Santillan-Garzón S; Benitez J; Osorio A
Breast Cancer Res Treat; 2017 Feb; 161(3):597-604. PubMed ID: 27913932
[TBL] [Abstract][Full Text] [Related]
19. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2009 May; 115(1):51-5. PubMed ID: 18483852
[TBL] [Abstract][Full Text] [Related]
20. An entire exon 3 germ-line rearrangement in the BRCA2 gene: pathogenic relevance of exon 3 deletion in breast cancer predisposition.
Muller D; Rouleau E; Schultz I; Caputo S; Lefol C; Bièche I; Caron O; Noguès C; Limacher JM; Demange L; Lidereau R; Fricker JP; Abecassis J
BMC Med Genet; 2011 Sep; 12():121. PubMed ID: 21939546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]